(Q51955997)

English

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. (English)

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

0 references

disseminated intravascular coagulation

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Kienast

1

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

M Juers

2

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

C J Wiedermann

3

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

J N Hoffmann

4

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

H Ostermann

5

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

R Strauss

6

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

H-O Keinecke

7

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

B L Warren

8

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

S M Opal

9

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

KyberSept investigators

10

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

publication date

1 January 2006

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

4

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

1

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

90-97

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

Review: infectious diseases and coagulation disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Sepsis and disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Disseminated intravascular coagulation in sepsis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Substitution of antithrombin III in shock and DIC: a randomized study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Antithrombin, heparin, and heparan sulfate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Heparin therapy in septicemia with disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Heparin therapy in bacterial septicemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Antithrombin-III transfusion in disseminated intravascular coagulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2005.01697.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2005.01697.X

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

1 reference

Europe PubMed Central

18 April 2018

http://europepmc.org/abstract/MED/16409457

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51955997&oldid=1584920991"